New scan could sharpen prostate cancer detection

NCT ID NCT04777071

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a special PET scan using a tracer called 68Ga-PSMA-11 can find prostate cancer more clearly than standard scans. About 141 men with prostate cancer at different stages will get the scan. The goal is to see if the scan changes how doctors plan treatment, such as switching from one therapy to another.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Gallium Ga 68 Gozetotide (a radioactive tracer used in PET scans)
What this could lead to
If successful, this imaging method could help doctors more accurately stage prostate cancer and choose the best treatment, potentially improving outcomes.
What could go wrong
This is a phase 2 trial with 141 participants, so results are still preliminary. The scan may not always change management or improve survival, and false positives are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BIOCHEMICALLY RECURRENT PROSTATE CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Fred Hutch/University of Washington Cancer Consortium

    Seattle, Washington, 98109, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.